hOKT3gamma1(Ala-Ala)

DRUG2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Arthritis, PsoriaticDiabetes Mellitus, Type 1

Phase 2

PsA Treatment With hOKT3γ1 (Ala-Ala)

TerminatedNCT00239720

National Institute of Allergy and Infectious Diseases (NIAID)Arthritis, Psoriatic

Start: 2006-03-16End: 2008-06-25Updated: 2017-04-27

Treatment With hOKT3gamma1(Ala-Ala) in T1DM

TerminatedNCT00806572

National Institute of Allergy and Infectious Diseases (NIAID)Diabetes Mellitus, Type 1

Start: 2002-05-31End: 2007-08-31Updated: 2017-02-08